Nobel Prize in Chemistry 2026: How a Tiny Bias in Molecular Handedness Gets Amplified
The Royal Swedish Academy of Sciences awarded the 2026 Nobel Prize in Chemistry to Henri B. Kagan (France) and Kenso Soai (Japan) on 7 October 2026.
The official citation: "for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis". Each laureate gets half of the prize of 12 million Swedish kronor.
The prize is about chirality, or molecular "handedness": many molecules exist in two mirror-image forms, like a left hand and a right hand.
Kagan showed in 1986 that a catalyst (a helper substance that speeds up a reaction) which is only partly of one handedness can still give a product that is much more strongly of one handedness. This is called a non-linear effect.
Soai showed in 1995 a reaction in which the product makes more copies of itself with the same handedness (asymmetric autocatalysis). A tiny starting imbalance grows until almost all the product is of one hand.
The work matters for making safer medicines, and it offers a possible chemical explanation for why living things use only one hand of their key molecules (a puzzle about the origin of life).
Chirality: Molecular Handedness and Enantiomers
Chirality is the property of an object that cannot be placed exactly on top of its mirror image. Your two hands are the best example: they are mirror images, but a left glove never fits a right hand. Many molecules are like this too. Such a molecule exists in two forms, a "left-handed" one and a "right-handed" one, and these two forms are called enantiomers.
The 2026 Chemistry Nobel is about how chemists can push a reaction to give mostly one hand of a chiral molecule, and how a tiny imbalance between the two hands can grow into near-total one-handedness. Understanding chirality is the first step to understanding why Kagan's and Soai's discoveries matter for medicines and for the origin of life.
Asymmetric Catalysis: How Chemists Make One Mirror-Image Form
Asymmetric catalysis is a way of making mostly one enantiomer (one "hand") of a chiral molecule instead of a 50:50 mixture. It uses a small amount of a chiral catalyst, a helper substance that is itself handed. The catalyst guides each reaction so that one hand of the product forms much faster than the other. One small batch of catalyst can produce a very large amount of product.
The 2026 prize honours two discoveries within asymmetric catalysis. Kagan showed that the handedness of a product need not simply copy the handedness of the catalyst, and Soai built a reaction where the product multiplies its own hand. Together they show how a tiny imbalance can be amplified, which helps chemists make purer medicines and suggests how life became one-handed.
- 2026 Chemistry Nobel: Henri B. Kagan (France) and Kenso Soai (Japan), announced 7 October 2026 by the Royal Swedish Academy of Sciences
- Citation: "for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis"
- Prize money: 12 million Swedish kronor, half to each laureate
- Kagan's non-linear effect: reported 1986 (sulfide oxidation, Sharpless epoxidation of geraniol, Hajos-Parrish reaction)
- Soai reaction: reported 1995; diisopropylzinc + pyrimidine-5-carbaldehyde gives a self-replicating chiral pyrimidyl alkanol
- Amplification later shown from about 0.00005% ee to over 99.5% ee
- Frank's theoretical model of asymmetric autocatalysis: 1953
- Life's homochirality: L-amino acids in proteins, D-sugars in DNA and RNA
- Earlier chirality Nobels in Chemistry: 2001 (Knowles, Noyori, Sharpless) and 2021 (List, MacMillan)
- Thalidomide (1957–1961): the classic example of why drug handedness matters